Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Stomach Neoplasms × Drug Delivery Systems × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 6 Glioblastoma 4 Urinary Bladder Neoplasms 3 Colorectal Neoplasms 3 Pancreatic Neoplasms 2 Lung Neoplasms 2 Glioma 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Brain Neoplasms 2 Astrocytoma 2 Uterine Cervical Neoplasms 1 Tuberculosis, Pulmonary 1 Thyroid Nodule 1 Stomach Neoplasms 1 Pulmonary Fibrosis 1 Pulmonary Embolism 1 Pulmonary Disease, Chronic Obstructive 1 Pulmonary Arterial Hypertension 1 Prostatic Neoplasms 1 Pleural Neoplasms 1 Pancreatic Cyst 1 Oropharyngeal Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Mouth Neoplasms 1 Medication Adherence 1 Margins of Excision 1 Lymphoma, Follicular 1 Lymphedema 1 Lung Injury 1

Interventions

Oxaliplatin 263 Capecitabine 185 Fluorouracil 165 Cisplatin 150 Docetaxel 124 S 1 (combination) 120 Paclitaxel 113 Leucovorin 110 Irinotecan 100 pembrolizumab 88 Trastuzumab 62 apatinib 55 Nivolumab 51 Drug Therapy 48 Surgical Procedures, Operative 39 Radiotherapy 39 sintilimab 38 Ramucirumab 36 Bevacizumab 34 Hyperthermic Intraperitoneal Chemotherapy 31 Carboplatin 30 tislelizumab 29 Epirubicin 29 titanium silicide 27 Gastrectomy 26 XELOX 24 Cyclophosphamide 24 Tegafur 21 Folfox protocol 20 camrelizumab 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05899985 2025-08-08

MAGMAP

Ferronova Pty Ltd

Phase NA Recruiting

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡